Phase 2 Dose-finding IMU-838 for Ulcerative Colitis

Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02

To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Acute Treatment Trial in Adult Subjects With Migraines

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease